A new hope for KRAS mutant cancers

Amaia Lujambio

doi:10.1126/scitranslmed.aas8964

A new hope for KRAS mutant cancers

Amaia Lujambio

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

c-RAF ablation in KRAS mutant lung tumors is highly efficacious, supporting the development of selective c-RAF inhibitors for clinical use.

Original language	English
Article number	eaas8964
Journal	Science Translational Medicine
Volume	10
Issue number	429
DOIs	https://doi.org/10.1126/scitranslmed.aas8964
State	Published - 21 Feb 2018

Access to Document

10.1126/scitranslmed.aas8964

Cite this

@article{2fabe6d8178c4334a77dc3701ceacbd5,

title = "A new hope for KRAS mutant cancers",

abstract = "c-RAF ablation in KRAS mutant lung tumors is highly efficacious, supporting the development of selective c-RAF inhibitors for clinical use.",

author = "Amaia Lujambio",

year = "2018",

month = feb,

day = "21",

doi = "10.1126/scitranslmed.aas8964",

language = "English",

volume = "10",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "429",

}

TY - JOUR

T1 - A new hope for KRAS mutant cancers

AU - Lujambio, Amaia

PY - 2018/2/21

Y1 - 2018/2/21

N2 - c-RAF ablation in KRAS mutant lung tumors is highly efficacious, supporting the development of selective c-RAF inhibitors for clinical use.

AB - c-RAF ablation in KRAS mutant lung tumors is highly efficacious, supporting the development of selective c-RAF inhibitors for clinical use.

UR - http://www.scopus.com/inward/record.url?scp=85042383642&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aas8964

DO - 10.1126/scitranslmed.aas8964

M3 - Review article

AN - SCOPUS:85042383642

SN - 1946-6234

VL - 10

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 429

M1 - eaas8964

ER -

A new hope for KRAS mutant cancers

Abstract

Access to Document

Fingerprint

Cite this